Cholesterol prevents interaction of the cell-penetrating peptide transportan with model lipid membranes

Journal of Peptide Science

Volumn 14, Issue 12, 2008, Pages 1303-1308

  Arsov, Zoran ^a   Nemec, Marjana ^a   Schara, Milan ^a   Johansson, Henrik ^b   Langel, Ülo ^b   Zorko, Matjaž ^c  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Cell penetrating peptide; Cholesterol; Lipid phase; Model lipid membranes; Spin label electron paramagnetic resonance; Transportan

Indexed keywords

CELL PENETRATING PEPTIDE; CHOLESTEROL; DIMYRISTOYLPHOSPHATIDYLCHOLINE; LIPOSOME;

ARTICLE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; LIPID MEMBRANE; MEMBRANE PERMEABILITY; MEMBRANE STRUCTURE; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION;

CHOLESTEROL; ELECTRON SPIN RESONANCE SPECTROSCOPY; GALANIN; LIPID BILAYERS; MEMBRANES, ARTIFICIAL; RECOMBINANT FUSION PROTEINS; WASP VENOMS;

EID: 61749101155     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1062     Document Type: Article

References (27)

1. Zorko M, Langel U. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv. Drug Delivery Rev. 2005; 57: 529-545.
2. Pooga M, Hällbrink M, Zorko M, Langel U. Cell penetration by transportan. FASEB J. 1998; 12: 67-77.
3. Pooga M, Kut C, Kihlmark M, Hallbrink M, Fernaeus S, Raid R, Land T, Hallberg E, Bartfai T, Langel U. Cellular translocation of proteins by transportan. FASEB J. 2001; 15: 1451-1453.
4. Lundberg P, Langel U. A brief introduction to cell-penetrating peptides. J. Mol. Recognit. 2003; 16: 227-233.
5. Yandek LE, Pokorny A, Floren A, Knoelke K, Langel U, Almeida PFF. Mechanism of the cell-penetrating peptide transportan 10 permeation of lipid bilayers. Biophys. J. 2007; 92: 2434-2444.
6. Oglecka K, Lundberg P, Magzoub M, Langel U, Gräslund A. Relevance of the N-terminal NLS-like sequence of the prion protein for membrane perturbation effects. Biochim. Biophys. Acta 2008; 1778: 206-213.
7. Christiaens B, Symoens S, Vanderheyden S, Engelborghs Y, Joliot A, Prochiantz A, Vandekerckhove J, Rosseneu M, Vanloo B. Tryptophan fluorescence study of the interaction of penetratin peptides with model membranes. Eur. J. Biochem. 2002; 269: 2918-2926.
8. Magzoub M, Eriksson LE, Gräslund A. Comparison of the interaction, positioning, structure induction and membrane perturbation of cell-penetrating peptides and non-translocating variants with phospholipid vesicles. Biophys. Chem. 2003; 103: 271-288.
9. Binder H, Lindblom G. A molecular view on the interaction of the trojan peptide penetratin with the polar interface of lipid bilayers. Biophys. J. 2004; 87: 332-343.
10. Barany-Wallje E, Andersson A, Gräslund A, Mäler L. NMR solution structure and position of transportan in neutral phospholipid bicelles. FEBS Lett. 2004; 567: 265-269.
11. Magzoub M, Kilk K, Eriksson LE, Langel U, Gräslund A. Interaction and structure induction of cell-penetrating peptides in the presence of phospholipid vesicles. Biochim. Biophys. Acta 2001; 1512: 77-89.
12. Ghibaudi E, Boscolo B, Inserra G, Laurenti E, Traversa S, Barbero L, Ferrari RP. The interaction of the cell-penetrating peptide penetratin with heparin, heparansulfates and phospholipid vesicles investigated by ESR spectroscopy. J. Pept. Sci. 2005; 11: 401-409.
13. Arsov Z, Strancar J. Determination of partition coefficient of spin probe between different lipid membrane phases. J. Chem. Inf. Model. 2005; 45: 1662-1671.
14. Strancar J, Koklic T, Arsov Z, Filipic B, Stopar D, Hemminga MA. Spin label EPR-based characterization of biosystem complexity. J. Chem. Inf. Model. 2005; 45: 394-406.
15. Pabst G, Hodzic A, Strancar J, Danner S, Rappolt M, Laggner P. Rigidification of neutral lipid bilayers in the presence of salts. Biophys. J. 2007; 93: 2688-2696.
16. Almeida PFF, Vaz WLC, Thompson TE. Lateral diffusion in the liquid phases of dimyristoylphosphatidylcholine/cholesterol lipid bilayers: a free volume analysis. Biochemistry 1992; 31: 6739-6747.
17. London E. How principles of domain formation in model membranes may explain ambiguities concerning lipid raft formation in cells. Biochim. Biophys. Acta 2005; 1746: 203-220.
18. El Jastimi R, Edwards K, Lafleur M. Characterization of permeability and morphological perturbations induced by nisin on phosphatidylcholine membranes. Biophys. J. 1999; 77: 842-852.
19. Hallock KJ, Lee D-K, Omnaas J, Mosberg HI, Ramamoorthy A. Membrane composition determines pardaxin's mechanism of lipid bilayer disruption. Biophys. J. 2002; 83: 1004-1013.
20. Pokorny A, Almeida PFF. Permeabilization of raft-containing lipid vesicles by δ-lysin: a mechanism for cell sensitivity to cytotoxic peptides. Biochemistry 2005; 44: 9538-9544.
21. Gomara MJ, Nir S, Nieva JL. Effects of sphingomyelin on melittin pore formation. Biochim. Biophys. Acta 2003; 1612: 83-89.
22. Bechinger B, Lohner K. Detergent-like actions of linear amphipathic cationic antimicrobial peptides. Biochim. Biophys. Acta 2006; 1758: 1529-1539.
23. Thoren PEG, Persson D, Lincoln P, Norden B. Membrane destabilizing properties of cell-penetrating peptides. Biophys. Chem. 2005; 114: 169-179.
24. Deshayes S, Plenat T, Charnet P, Divita G, Molle G, Heltz F. Formation of transmembrane ionic channels of primary amphipathic cell-penetrating peptide. Consequences on the mechanism of cell penetration. Biochim. Biophys. Acta 2006; 1758: 1846-1851.
25. Henriques ST, Quintas A, Bagatolli LA, Homble F, Castanho MARB. Energy-independent translocation of cell-penetrating peptides occurs without formation of pores. A biophysical study with pep-1. Mol. Membr. Biol. 2007; 24: 282-293.
26. Mally M, Majhenc J, Svetina S, Zeks B. The response of giant phospholipid vesicles to pore-forming peptide melittin. Biochim. Biophys. Acta 2007; 1768: 1179-1189.
27. Erjavec V, Pavlica Z, Sentjurc M, Petelin M. In vivo study of liposomes as drug carriers to oral mucosa using EPR oximetry. Int. J. Pharm. 2006; 307: 1-8.